17 - 20 Jun 2024 | Amsterdam

Keynote: Transforming Perspectives on Psychedelics: A Journey Beyond the Trip

Speakers:

About this Session:

In August 2023, UK-based COMPASS Pathways raised $285 million for psilocybin therapy in mental health. Whilst it remains to be seen if this was a watershed moment, it certainly made everyone in Europe sit up and take notice. Join us as esteemed speakers Kabir Nath and Florian Brand share their insights and expertise on this burgeoning field. Kabir Nath, CEO of Compass Pathways, offers his perspectives on how evidence-based psychedelic treatment could potentially revolutionise mental health care. "Millions of people across the world live with mental illnesses for which there are few good options. We are determined to change that. We urgently need more innovative medicines for difficult-to-treat mental health conditions, and we need to ensure broad and equitable access to those who could benefit from them”Florian Brand is the CEO and Co-Founder of atai Life Sciences, a biotech company on a mission to develop scalable psychedelic-based therapies to enable people to heal from mental health conditions. “Healing is more than symptom reduction. It often means getting to the root causes, helping people to truly get better. Our goal is to develop effective, accessible and more convenient mental health care options for those let down by the care they’re receiving today.”Moderated by Genevieve Jurvetson, Co-Founder of The Jurvetson Foundation, this session will steer clear of clichés and tired tropes, offering a fresh, forward-thinking exploration of psychedelics.